(19)
(11)
EP 1 322 325 A1
(12)
(43)
Date of publication:
02.07.2003
Bulletin 2003/27
(21)
Application number:
01952780.3
(22)
Date of filing:
16.07.2001
(51)
International Patent Classification (IPC)
7
:
A61K
39/00
,
A61K
39/385
,
A01N
43/40
,
A01N
43/42
(86)
International application number:
PCT/US0122/335
(87)
International publication number:
WO 0200/7761
(
31.01.2002
Gazette 2002/05)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
(30)
Priority:
20.07.2000
US 219550 P
(71)
Applicant:
Merck & Co., Inc.
Rahway,New Jersey 07065-0907 (US)
(72)
Inventor:
WAXMAN, Lloyd, H.
Rahway, NJ 07065-0907 (US)
(74)
Representative:
Thompson, John Dr. et al
Merck & Co., Inc.European Patent DepartmentTerlings ParkEastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)
(54)
INHIBITING HEPATITIS C VIRUS PROCESSING AND REPLICATION